Clinical Trial Update: Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated inhaled nitric oxide for preventing chronic lung disease, including bronchopulmonary dysplasia, in premature infants and has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Lung Disease of Prematurity

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Lung Diseases, Bronchopulmonary Dysplasia | Phase 3 | Status: COMPLETED